Found: 12
Select item for more details and to access through your institution.
Therapeutic targeting of circ‐CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 12, p. N.PAG, doi. 10.15252/emmm.201910835
- By:
- Publication type:
- Article
HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00857-7
- By:
- Publication type:
- Article
Correction: Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Long-Term Survival of Neuroblastoma Patients Receiving Surgery, Chemotherapy, and Radiotherapy: A Propensity Score Matching Study.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 3, p. 754, doi. 10.3390/jcm12030754
- By:
- Publication type:
- Article
Robot-Assisted versus Trans-Umbilical Multiport Laparoscopic Ureteral Reimplantation for Pediatric Benign Distal Ureteral Stricture: Mid-Term Results at a Single Center.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 21, p. 6229, doi. 10.3390/jcm11216229
- By:
- Publication type:
- Article
p113 isoform encoded by CUX1 circular RNA drives tumor progression via facilitating ZRF1/BRD4 transactivation.
- Published in:
- Molecular Cancer, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12943-021-01421-8
- By:
- Publication type:
- Article
Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation.
- Published in:
- Molecular Cancer, 2019, v. 18, n. 1, p. 1, doi. 10.1186/s12943-019-1094-z
- By:
- Publication type:
- Article
Therapeutic Targeting of MZF1‐AS1/PARP1/E2F1 Axis Inhibits Proline Synthesis and Neuroblastoma Progression.
- Published in:
- Advanced Science, 2019, v. 6, n. 19, p. N.PAG, doi. 10.1002/advs.201900581
- By:
- Publication type:
- Article
Therapeutic targeting of CNBP phase separation inhibits ribosome biogenesis and neuroblastoma progression via modulating SWI/SNF complex activity.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 4, p. 1, doi. 10.1002/ctm2.1235
- By:
- Publication type:
- Article
Therapeutic targeting of SPIB/SPI1‐facilitated interplay of cancer cells and neutrophils inhibits aerobic glycolysis and cancer progression.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 11, p. 1, doi. 10.1002/ctm2.588
- By:
- Publication type:
- Article
Circ‐CTNNB1 drives aerobic glycolysis and osteosarcoma progression via m6A modification through interacting with RBM15.
- Published in:
- Cell Proliferation, 2023, v. 56, n. 1, p. 1, doi. 10.1111/cpr.13344
- By:
- Publication type:
- Article
Retraction Note: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice